Ghebremedhin E - Search Results

1

TDP-43 pathology is associated with increased tau burdens and seeding.

Tomé SO, Tsaka G, Ronisz A, Ospitalieri S, Gawor K, Gomes LA, Otto M, von Arnim CAF, Van Damme P, Van Den Bosch L, Ghebremedhin E, Laureyssen C, Sleegers K, Vandenberghe R, Rousseau F, Schymkowitz J, Thal DR. Tomé SO, et al. Among authors: ghebremedhin e. Mol Neurodegener. 2023 Sep 30;18(1):71. doi: 10.1186/s13024-023-00653-0. Mol Neurodegener. 2023. PMID: 37777806 Free PMC article.

2

LATE-NC aggravates GVD-mediated necroptosis in Alzheimer's disease.

Koper MJ, Tomé SO, Gawor K, Belet A, Van Schoor E, Schaeverbeke J, Vandenberghe R, Vandenbulcke M, Ghebremedhin E, Otto M, von Arnim CAF, Balusu S, Blaschko MB, De Strooper B, Thal DR. Koper MJ, et al. Among authors: ghebremedhin e. Acta Neuropathol Commun. 2022 Sep 3;10(1):128. doi: 10.1186/s40478-022-01432-6. Acta Neuropathol Commun. 2022. PMID: 36057624 Free PMC article.

3

Homozygosity for the K variant of BCHE gene increases the risk for development of neurofibrillary pathology but not amyloid deposits at young ages.

Ghebremedhin E, Thal DR, Schultz C, Braak H, Deller T. Ghebremedhin E, et al. Acta Neuropathol. 2007 Oct;114(4):359-63. doi: 10.1007/s00401-007-0276-8. Epub 2007 Aug 16. Acta Neuropathol. 2007. PMID: 17701416

4

Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years.

Braak H, Thal DR, Ghebremedhin E, Del Tredici K. Braak H, et al. Among authors: ghebremedhin e. J Neuropathol Exp Neurol. 2011 Nov;70(11):960-9. doi: 10.1097/NEN.0b013e318232a379. J Neuropathol Exp Neurol. 2011. PMID: 22002422

5

Age-dependent association between butyrylcholinesterase K-variant and Alzheimer disease-related neuropathology in human brains.

Ghebremedhin E, Thal DR, Schultz C, Braak H. Ghebremedhin E, et al. Neurosci Lett. 2002 Mar 1;320(1-2):25-8. doi: 10.1016/s0304-3940(02)00014-9. Neurosci Lett. 2002. PMID: 11849755

6

Cerebral amyloid angiopathy and its relationship to Alzheimer's disease.

Thal DR, Griffin WS, de Vos RA, Ghebremedhin E. Thal DR, et al. Among authors: ghebremedhin e. Acta Neuropathol. 2008 Jun;115(6):599-609. doi: 10.1007/s00401-008-0366-2. Epub 2008 Mar 28. Acta Neuropathol. 2008. PMID: 18369648 Review.

7

Modified amyloid variants in pathological subgroups of β-amyloidosis.

Gerth J, Kumar S, Rijal Upadhaya A, Ghebremedhin E, von Arnim CAF, Thal DR, Walter J. Gerth J, et al. Among authors: ghebremedhin e. Ann Clin Transl Neurol. 2018 Jun 6;5(7):815-831. doi: 10.1002/acn3.577. eCollection 2018 Jul. Ann Clin Transl Neurol. 2018. PMID: 30009199 Free PMC article.

8

Two types of sporadic cerebral amyloid angiopathy.

Thal DR, Ghebremedhin E, Rüb U, Yamaguchi H, Del Tredici K, Braak H. Thal DR, et al. Among authors: ghebremedhin e. J Neuropathol Exp Neurol. 2002 Mar;61(3):282-93. doi: 10.1093/jnen/61.3.282. J Neuropathol Exp Neurol. 2002. PMID: 11895043

9

Vascular pathology in Alzheimer disease: correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline.

Thal DR, Ghebremedhin E, Orantes M, Wiestler OD. Thal DR, et al. Among authors: ghebremedhin e. J Neuropathol Exp Neurol. 2003 Dec;62(12):1287-301. doi: 10.1093/jnen/62.12.1287. J Neuropathol Exp Neurol. 2003. PMID: 14692704

10

Inverse relationship between cerebrovascular lesions and severity of lewy body pathology in patients with lewy body diseases.

Ghebremedhin E, Rosenberger A, Rüb U, Vuksic M, Berhe T, Bickeböller H, de Vos RA, Thal DR, Deller T. Ghebremedhin E, et al. J Neuropathol Exp Neurol. 2010 May;69(5):442-8. doi: 10.1097/NEN.0b013e3181d88e63. J Neuropathol Exp Neurol. 2010. PMID: 20418782

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page